- Home
- FSP vs CLNN Comparison
FSP vs CLNN Comparison
Compare FSP & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FSP | CLNN |
|---|---|---|
| Founded | 1981 | 2012 |
| Country | United States | United States |
| Employees | N/A | 76 |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.7M | 69.7M |
| IPO Year | 2001 | N/A |
Fundamental Metrics
Financial Performance| Metric | FSP | CLNN |
|---|---|---|
| Price | $0.60 | $6.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $32.67 |
| AVG Volume (30 Days) | ★ 614.8K | 60.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 6.67% | N/A |
| EPS Growth | ★ 15.69 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $107,162,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $25,771.15 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.59 | $2.28 |
| 52 Week High | $1.93 | $13.50 |
Technical Indicators
Market Signals| Indicator | FSP | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 33.03 | 63.94 |
| Support Level | N/A | $5.59 |
| Resistance Level | $0.89 | $6.88 |
| Average True Range (ATR) | 0.06 | 0.49 |
| MACD | -0.01 | 0.11 |
| Stochastic Oscillator | 3.39 | 69.74 |
Price Performance
Historical ComparisonAbout FSP Franklin Street Properties Corp.
Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The principal revenue sources for its real estate operations include rental income from real estate leasing, property dispositions and fee income from asset/property management and development. The company provides asset management, property management, property accounting, investor and/or development services to its portfolio and Sponsored REIT through the company's subsidiaries.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.